Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,189 total articles
Amazon heads into its 02/05/2026 earnings report with the stock near $244 and momentum still constructive. The market’s attention will gravitate to AWS growth and AI-related capex, but the trade idea here leans on a quieter point: Amazon’s retail plus advertising machine can provide downside stability even if the AI narrative gets choppy. This is a…
BitMine Immersion (BMNR) is best understood as an ETH treasury vehicle: it acquires, holds, and actively manages Ethereum as its primary reserve asset, with staking/yield expectations doing much of the narrative work. The stock is trading below key moving averages with bearish MACD momentum and a middling RSI, which sets up a tactical long if it re…
CoStar has been volatile, but the latest capital-return and profitability signals matter. With the stock near $66 and below key longer-term moving averages, this trade leans on a fundamental catalyst stack (buyback + 2026 EBITDA targets + moderating Homes.com spend) and improving momentum indicators. The risk is straightforward: the valuation remai…
Community Financial System (CBU) isn’t a flashy bank, but it checks the boxes that matter in this tape: decent returns on equity, modest leverage, and a valuation that doesn’t assume perfection. With the stock around $61 and a 3.0% dividend yield, the trade is about buying a high-quality regional name on a pullback level and looking for a move back…
Powell Industries is in a momentum phase where the market is paying up for operational discipline. With the stock pressing 52-week highs, bullish MACD, and strong profitability metrics, the trade is less about finding a bargain and more about managing entry and risk in an overbought name with real fundamental backing.
BlackRock remains a premier asset manager with a durable product mix across single-asset and multi-asset portfolios, advisory, and risk management. But with BLK still valued at roughly 28.5x earnings and about 3.1x book, the stock needs either a cleaner technical reset or a clear catalyst to justify adding risk. This trade idea frames BLK as a hold…
Rogers has pushed to a fresh 52-week high and is now pulling back in an orderly way while still holding above key medium-term moving averages. With short interest running around 6 days to cover and recent short volume consistently elevated, the setup favors a long trade if price stabilizes above the low-$97s and reclaims $98+. The trade is mid-term…
S&P Global is down from its highs and sitting near $530, while still trading at a premium valuation. The setup is straightforward: you’re buying an entrenched data, indices, and credit ratings franchise with durable demand drivers, modest leverage, and strong cash generation. This trade idea targets a long-term (180 trading days) hold with defined …
Affirm (AFRM) is trading near $68 after a sharp pullback, with momentum bearish but RSI nearing oversold. The broader setup is that BNPL is shifting from discretionary retail into routine, needs-based spend, and that transition can expand addressable volume while drawing more scrutiny. This trade idea looks for a mean-reversion bounce back toward k…
PVH has slid back toward its 52-week lows even as profitability metrics and cash generation remain solid on paper. At roughly $61, the stock trades at single-digit earnings and mid-single-digit EV/EBITDA with a sub-0.6x price-to-book multiple. This setup looks less like “broken business” and more like “broken sentiment,” creating a mid-term trade o…
Expedia Group has rallied hard into early 2026, then backed off as momentum cooled. Even with that rally, valuation still looks defensible when you anchor on free cash flow, EV/EBITDA, and a business that is showing tangible operating leverage. Technically, the stock is working off overbought conditions with RSI in the low 40s and price below short…
Advanced Energy (AEIS) has rallied to fresh highs on booming AI data center power demand and improving results. While valuation is rich at roughly 69x earnings, technical momentum remains bullish and catalysts into 2026 could keep the bid under the stock. This trade idea focuses on riding the trend with defined risk, using a pullback entry and a st…
Nano Labs is a micro-cap semiconductor design company that has increasingly been framed by the market as a crypto-reserve and Web3 optionality story, anchored around BNB accumulation. With the stock back above key short- and intermediate-term moving averages and MACD in bullish momentum, the trade skews long as long as price holds above the recent …
Cabaletta Bio (CABA) is a clinical-stage autoimmune cell therapy name with improving momentum, elevated short interest (about 11 days to cover), and several upcoming clinical and regulatory milestones. With the stock reclaiming key moving averages and still far below its 52-week high, this is a tactically interesting long trade. The setup is not ab…
Tesla’s stock is consolidating near $435 after a mild pullback, with momentum still soft but not broken. The market is paying a steep price for future software-like economics, and the TAAS narrative is the clearest path to justify that valuation. This trade idea looks for a reclaim of near-term trend levels with a tight stop, aiming for a push back…
Western Alliance (WAL) is acting like a regional bank that has regained its footing: the stock is holding above rising intermediate-term averages, valuation is still modest at ~11x earnings, and sentiment remains cautious enough to fuel upside if the market keeps warming to financials. With shares pulling back to the high-$80s, I like this as an up…
Tractor Supply has quietly rebuilt upside momentum into earnings while fundamentals still read like a quality compounder: strong ROE (about 43%), solid ROA (about 10%), and manageable leverage (debt-to-equity ~0.69). At roughly $29B market cap and ~26.6x earnings, the stock isn’t cheap, but it looks reasonable if 2026 guidance supports accelerating…
Boeing just put up the kind of order headline bulls want, but the tape is reminding investors that execution and cash conversion matter more than trophies. BA is down from its 01/22/2026 52-week high even as sentiment improves, creating a tradable long setup if price can reclaim key moving averages. This is a mid-term (45 trading days) trade idea b…
Apple is trading near $261 with improving momentum and a valuation that looks easier to defend than it did a few weeks ago, even though the product technology narrative (especially around AI-led form factors) still feels more speculative than confirmed. This sets up a pragmatic mid-term long trade: buy strength above key moving averages, target a m…
Clover Health is trading at $2.33 with a roughly $1.2B market cap and an EV/Sales near 0.7, while short interest remains elevated and technicals are oversold-leaning. The setup looks like a classic “left-for-dead” healthcare name where a modest improvement in profitability expectations can re-rate the stock quickly. This trade idea targets a move b…
Arista Networks sits in the critical “picks and shovels” layer of AI buildouts: high-speed switching, routing, and software that keeps data centers from choking on bandwidth. The stock is extended but technically strong, with bullish momentum signals and a clear level to define risk. This trade idea leans long, targeting a push back toward the prio…
Fortinet has the profile of a “boring” cybersecurity compounder that tends to look most interesting when the tape is choppy and the narrative turns temporarily negative. The stock is down materially from its $114.82 52-week high and is now trading around $81.57, even as the company continues to generate meaningful free cash flow and maintains stron…
Credo Technology is a pure-play on high-speed connectivity inside AI data centers. After a sharp drawdown from its 52-week high, CRDO is now trading with a depressed RSI and below key moving averages, setting up a defined-risk dip-buy trade. The bull case leans on real operating momentum (including triple-digit revenue growth cited in recent covera…
Lemonade has been trading like a momentum stock, but the underlying story the market is buying is simpler: AI-driven distribution plus better loss performance, inching the model toward profitability. With shares near $90 after a sharp run to $99.90, LMND offers a defined-risk long setup using the rising 10-day/20-day trend as a line in the sand. Th…
REGENXBIO (RGNX) is a clinical-stage gene therapy name with a clear event-window setup: a key FDA decision on its Hunter syndrome program is approaching, and the stock is coiling below near-term technical levels. With a ~$701M market cap, negative EPS (-$3.51), and meaningful short interest (about 5.0M shares; ~7.3 days to cover), price action can …
